Pharmacological inhibition of CDK7 by THZ1 impairs tumor growth in p53‐mutated HNSCC
Cyclin‐dependent kinase 7 (CDK7) has been critically linked to human cancer. However, the roles of CDK7 in head and neck squamous cell carcinoma (HNSCC) remain incompletely known.